(Q45025706)

English

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1

object named as

Lieuwe de Haan

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Thérèse A.M.J. Van Amelsvoort

2

object named as

Therese van Amelsvoort

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

4

object named as

Don Linszen

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Kim Rosien

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

number of pages

2

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

175

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

389-390

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-004-1951-2

0 references

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical diseases in schizophrenia and affective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonergic control of the organization of feeding and satiety

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-004-1951-2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45025706&oldid=2112656870"